Business Wire

Strata Oncology Announces Presentations on Proprietary Multivariate Biomarkers at North America Conference on Lung Cancer and San Antonio Breast Cancer Symposium

ANN ARBOR, Mich.--(BUSINESS WIRE)--Strata Oncology, Inc. (“Strata”), a next-generation precision oncology company enabling smarter cancer treatment, today announced that it will present new data in ...
Business Insider

Apollomics Announces Presentation of Vebreltinib Data at the 2023 IASLC North America Conference on Lung Cancer (NACLC)

FOSTER CITY, Calif., Nov. 28, 2023 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM) (the “Company”), a late-stage clinical biopharmaceutical company developing multiple oncology drug candidates to ...
MedPage Today

NACLC | MedPage Today

North America Conference on Lung Cancer Meeting Coverage NACLC North America Conference on Lung Cancer See All in Meeting Coverage AAAAI AACE AACR AAD AAIC AAN AANEM AAO AAOS AAP AASLD ACAAI ACC ACG ...
Seeking Alpha

BeyondSpring Announces New Analyses of DUBLIN-3 Phase 3 Study Showing Survival Benefit of Plinabulin + Docetaxel in Post Anti-PD-(L)1 for Non-squamous EGFR WT NSCLC and a ...

In DUBLIN-3 non-squamous EGFR WT NSCLC patients who progressed after anti-PD-(L)1, Plinabulin + docetaxel showed consistent and clinically meaningful improvements in OS, PFS, and ORR, reinforcing ...
Business Wire

Median Technologies to Speak at the IASLC 2023 North America Conference on Lung Cancer (NACLC), Dec. 1-3, Chicago, IL, USA, with two Presentations

SOPHIA ANTIPOLIS, France--(BUSINESS WIRE)--Regulatory News: Median Technologies (Paris:ALMDT) announced today that the Company will be presenting two scientific posters at the 2023 North America ...
MedPage Today

NACLC News - Pulmonology | MedPage Today

Visit us on Facebook. Opens in a new tab or window Visit us on X. Opens in a new tab or window Visit us on Instagram. Opens in a new tab or window Visit us on ...